State of New Jersey Common Pension Fund D’s SpringWorks Therapeutics SWTX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,705	Closed	-$1.91M	–	1513
2025 Q2	$1.91M	Buy	40,705 +6,502	+19%	+$289K	0.01%	1242
2025 Q1	$1.51M	Sell	34,203 -21,140	-38%	-$973K	0.01%	1419
2024 Q4	$2M	Buy	55,343 +8,954	+19%	+$313K	0.01%	1248
2024 Q3	$1.49M	Buy	46,389 +871	+2%	+$32.5K	0.01%	1501
2024 Q2	$1.71M	Sell	45,518 -11,993	-21%	-$505K	0.01%	1419
2024 Q1	$2.83M	Buy	+57,511	New	+$2.66M	0.01%	1308

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

State of New Jersey Common Pension Fund D's SWTX Position: Q3 2025 in Review

State of New Jersey Common Pension Fund D sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 40,705 shares — an estimated $1.91M sold.

State of New Jersey Common Pension Fund D first reported a position in SWTX in Q1 2024 and held it in 6 quarters. The position peaked at $2.83M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

State of New Jersey Common Pension Fund D reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 40,705 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.91M.
State of New Jersey Common Pension Fund D first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 6 quarters.
State of New Jersey Common Pension Fund D's SpringWorks Therapeutics position peaked at $2.83M in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2025, filed 7 Nov 2025.